ORBIMED ADVISORS LLC Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Loxo Oncology, Inc. ($LOXO).

ORBIMED ADVISORS LLC in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,151,283 shares
Current Value: $244,321,210
Latest Transaction: Apr 15 2013
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in INTERCEPT PHARMACEUTICALS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CCXI, ICPT, LOXO, RLYP, RPBIF, ROKA, SUPN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 15 2013	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Option Exercise	M	0.00	649	0	1,947
Apr 15 2013	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Buy	M	0.00	649	0	2,151,283	2.2 M to 2.2 M (+0.03 %)

Page: 1